Astrana Health (NASDAQ:ASTH) Sets New 52-Week High – Here’s Why

Posted by Stanley Muller on Jun 22nd, 2026

Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) hit a new 52-week high on Monday . The stock traded as high as $40.58 and last traded at $39.6450, with a volume of 67712 shares traded. The stock had previously closed at $39.17.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on ASTH. Robert W. Baird set a $45.00 target price on Astrana Health in a report on Friday, May 8th. Truist Financial increased their target price on shares of Astrana Health from $38.00 to $47.00 and gave the stock a “buy” rating in a research report on Thursday, May 14th. Weiss Ratings upgraded shares of Astrana Health from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 1st. BTIG Research restated a “buy” rating and issued a $50.00 target price on shares of Astrana Health in a report on Tuesday, June 2nd. Finally, TD Cowen raised their price target on Astrana Health from $35.00 to $45.00 and gave the company a “buy” rating in a research report on Tuesday, May 12th. Seven research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, Astrana Health currently has a consensus rating of “Moderate Buy” and an average price target of $45.00.

View Our Latest Report on ASTH

Astrana Health Stock Performance

The stock’s 50 day moving average is $36.10 and its two-hundred day moving average is $28.10. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.35 and a quick ratio of 1.35. The firm has a market capitalization of $2.22 billion, a P/E ratio of 65.25 and a beta of 1.00.

Astrana Health (NASDAQ:ASTH – Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.74 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.45. The firm had revenue of $965.10 million during the quarter, compared to analysts’ expectations of $949.21 million. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The business’s revenue for the quarter was up 55.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.42 earnings per share. As a group, equities analysts anticipate that Astrana Health, Inc. will post 1.25 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Astrana Health

Large investors have recently modified their holdings of the stock. Bank of America Corp DE grew its position in shares of Astrana Health by 13.3% during the 1st quarter. Bank of America Corp DE now owns 574,729 shares of the company’s stock worth $14,092,000 after purchasing an additional 67,628 shares in the last quarter. Edgestream Partners L.P. boosted its stake in shares of Astrana Health by 68.3% in the 1st quarter. Edgestream Partners L.P. now owns 27,616 shares of the company’s stock valued at $677,000 after purchasing an additional 11,209 shares during the last quarter. California State Teachers Retirement System grew its position in shares of Astrana Health by 24.5% during the 1st quarter. California State Teachers Retirement System now owns 51,371 shares of the company’s stock worth $1,260,000 after buying an additional 10,102 shares during the period. Quantinno Capital Management LP raised its position in shares of Astrana Health by 69.4% during the first quarter. Quantinno Capital Management LP now owns 64,509 shares of the company’s stock worth $1,582,000 after purchasing an additional 26,418 shares during the period. Finally, Renaissance Technologies LLC lifted its holdings in shares of Astrana Health by 12.2% in the first quarter. Renaissance Technologies LLC now owns 104,546 shares of the company’s stock valued at $2,563,000 after purchasing an additional 11,400 shares in the last quarter. 52.77% of the stock is owned by institutional investors.

Astrana Health Company Profile

(Get Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.